Bio-Intervention Specialists (Bio-IS) and HSS Inc. (HSS) Announce a Five-Year Partnership to Deliver a 21st Century

Unique disinfection service utilizes a revolutionary, newly registered EPA Disinfectant that is Category IV practically non-toxic, environmentally friendly and offers a six log kill (99.9999%)

ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Bio-Intervention Specialists (Bio-IS) and HSS Inc. (HSS) announced today that their companies have signed a five-year partnership to deliver the Bio-Intervention Disinfection Service to hospitals across the United States.

Bio-IS has launched the newly EPA-registered Electro-BioCide disinfectant and its Bio-Intervention protocol into the U.S. health care market. HSS is one of the nation’s leading healthcare outsourcing companies, having been ranked by Modern Healthcare as the 6th largest in the industry. Together, HSS and Bio-IS will provide hospitals the Bio-Intervention Disinfection Service, a 21st century solution to the challenge of hard-surface disinfection.

Today, most hospitals follow the same approach to hard-surface disinfection as they have for the past 35 years: a housekeeper, using a spray bottle and rag. Through the power of Mother Nature and mutation, this legacy approach is no longer effective against the superbugs of the 21st century.

Utilizing the newly EPA-registered Electro-BioCide disinfectant, the companies have certified Bio-Intervention Technicians that use portable electrostatic sprayers to comprehensively disinfect the hard surfaces of hospitals and healthcare facilities using a specific, step-by-step, protocol. This combination of skilled specialists and innovative technology solves the current weak links of hard surface infection control.

Tom Boyer, President and CEO of Bio-IS, said, “We are very excited about this partnership because of the outstanding reputation of HSS and their 90+% customer retention rates. Their commitment to quality is second to none and we are honored to have them as our partner. Both companies are truly committed to saving lives and reducing costs through the Bio-Intervention Disinfection Service.”

“Reducing hospital-acquired infections will save lives and reduce costs,” said Wayne Schell, CEO, HSS. “We are pleased to partner with Bio-IS to deliver a solution that will help healthcare providers combat these deadly and costly infections.”

This service is currently available in 35 states. The companies expect complete national coverage in early 2011. Teams are available for either emergent or continuous on-site deployment. For more information contact (800) 699-4230.

About HSS Inc.

Founded in Denver in 1967, HSS is a $100 million private company with 2,600 employees in 12 states. The company has earned the Small Business Advocate of the Year Award from the Greater Orlando Airport Authority for mentoring minority-owned businesses. HSS was also recognized recently by the American Legion for its efforts in training and employing veterans.

About Bio-Intervention Specialists (Bio-IS)

Bio-Intervention Specialists is a dba of Aion Partners LLC and is privately held, owned by its founders and employees, physicians, senior executives in the healthcare sector, and other private investors. The founder and CEO is Tom Boyer, with almost 20 years of experience in the healthcare sector. He served on the Board of HCA/HealthONE LLC (the largest hospital company in Colorado), as Chairman of the Colorado Health Foundation, and was founding Chairman of the Colorado Center for Nursing Excellence. Visit www.Bio-Intervention.com for more information.



CONTACT:

Bio-Intervention Specialists (Bio-IS)
Media contact:
Lauri Harrison, 303-885-4200
[email protected]
or
Company contact:
Tom Boyer, 800-699-4230
President and CEO
[email protected]
or
HSS contact:
Mercedes Merchant, 303-603-3045
Bio-IS Operations Manager
[email protected]

KEYWORDS:   United States  North America  Colorado

INDUSTRY KEYWORDS:   Health  Biotechnology  Hospitals  Infectious Diseases  Medical Supplies  Managed Care

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.